Yan et al. (2019) demonstrated that lung cancer patients with high HNRNPC expression levels had short survival times and poor prognosis, which was consistent with our results. Huang et al. (2016a) also reported that high level of HNRNPC transcript indicated poor overall survival and progression-free survival. The gene discussed is HNRNPC; the disease is lung carcinoma.